Friday, November 13, 2026

US Dollar Plunges 10.8% in 2026 as Currency Markets Realign Globally

The US Dollar Index has dropped 10.8% in early 2026 to its lowest level since 2022, triggering a global currency realignment. The British pound fell below $1.31 amid UK budget uncertainty, while emerging market currencies face acute pressure and safe-haven flows shift toward the Swiss franc.

LM Salvado
LM Salvado

March 15, 2026

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
US Dollar Plunges 10.8% in 2026 as Currency Markets Realign Globally
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The US Dollar Index has plummeted 10.8% in early 2026, hitting its lowest point since 2022 and forcing a major recalibration across global foreign exchange markets. The decline reverses years of dollar strength and reshapes international capital flows.

The British pound dropped 0.5% to $1.3086, erasing some of its 7% gains from 2025. Jordan Rochester at Mizuho Bank forecasts sterling could breach $1.30 as UK Chancellor Rachel Reeves prepares her November 26 budget statement. Against the euro, the pound fell 0.4% to €1.13, its weakest since April 2023.

UK government bond markets show mounting stress. The 30-year gilt yield climbed to 5.21%, the highest since 1998, as investors demand higher returns. Demand for inflation-linked UK debt hit record levels, with £69 billion in bids for £4.25 billion in bonds, surpassing March's £67.5 billion record.

The anticipated Federal Reserve chair transition in June 2026 adds uncertainty to dollar positioning. Investors are rotating into the Swiss franc for stability as currency volatility intensifies across major markets.

Emerging economies face acute pressure from the dollar's weakness. Turkey's lira suffered sharp declines as carry trades collapsed, with leveraged investors unwinding positions built during the dollar's previous strength. The currency shifts are forcing international banks to adjust cross-border exposure and hedge exchange rate risk.

Neil Wilson at Saxo Markets warns fiscal instability concerns are spreading across markets. Kathleen Brooks at XTB notes that 25% of UK government debt is inflation-linked, compared to roughly 10% in the US and France, amplifying Britain's sensitivity to currency moves and inflation expectations. Investment portfolios with significant dollar or sterling exposure are being restructured to reflect the new currency dynamics.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· March 7, 2026
    Ray Dalio says America is facing a ‘debt death spiral’ — but you can protect your portfolio with these 3 assets
  3. [3]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  4. [4]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com